Comparison of effects of nitric oxide synthase (NOS) inhibitors on plasma nitrite/nitrate levels and tissue NOS activity in septic organs

Microbiology and Immunology

Volumn 49, Issue 2, 2005, Pages 139-147

  Hayashi, Yuri ^a   Abe, Masayoshi ^a   Murai, Akira ^a   Shimizu, Naomi ^a   Okamoto, Iku ^a   Katsuragi, Takeshi ^a   Tanaka, Keiichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Inducible nitric oxide synthase; Lipopolysaccharide; Nitric oxide; NOS inhibitor

Indexed keywords

2 AZA 7 CHLORO 3 IMINO 5 METHYLBICYCLO[4.1.0]HEPTANE; 7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO[4.1.0]HEPTANE; ACETAMIDINE DERIVATIVE; AMINOGUANIDINE; BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; HEART; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SEPSIS; TISSUE INJURY;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 14944358221     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03713.x     Document Type: Article

References (32)

1. Bone, R.C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115: 457-469.
2. Booke, M., Hinder, F., Traber, L.D., McGuire, R., and Traber, D.L. 1995. S-ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep. Shock 4: 274-281.
3. Bredt, D.S., and Snyder, S.H. 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86: 9030-9033.
4. Bredt, D.S., and Snyder, S.H. 1994. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63: 175-195.
5. Crespo, E., Macías, M., Pozo, D., Escames, G., Martín, M., Vives, F., et al. 1999. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide- induced multiple organ dysfunction syndrome in rats. FASEB J. 13: 1537-1546.
6. Deitch, E.A. 1992. Multiple organ failure. Ann. Surg. 216: 117-134.
7. Gardiner, S.M., Kemp, P.A., March, J.E., and Bennett, T. 1995. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol. 116: 2005-2016.
8. Garvey, E.P., Oplinger, J.A., Furfine, E.S., Kiff, R.J., Laszlo, F., Whittle, B.J.R., et al. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272: 4959-4963.
9. Hinshaw, L.B. 1996. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit. Care Med. 24: 1072-1078.
10. Kirkebøen, K.A., and Strand, Ø.A. 1999. The role of nitric oxide in sepsis-an overview. Acta Anaesthesiol. Scand. 43: 275-288.
11. Kroncke, K.D., Fehsel, K., and Kolb-Bachofen, V. 1998. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113: 147-156.
12. MacMicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D.S., Trumbauer, M., et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650.
13. Moncada, S., Palmer, R.M., and Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142.
14. Nagasaki, A., Gotoh, T., Takeya, M., Yu, Y., Takiguchi, M., Matsuzaki, H., et al. 1996. Coinduction of nitric oxide synthase, argininosuccinate synthase, and argininosuccinate lyase in lipopolysaccharide-treated rats. J. Biol. Chem. 271: 2658-2662.
15. Naka, M., Nanbu, T., Kobayashi, K., Kamanaka, Y., Komeno, M., Yanase, R., et al. 2000. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative. Biochem. Biophys. Res. Commun. 270: 663-667.
16. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064.
17. Okamoto, I., Abe, M., Shibata, K., Shimizu, N., Sakata, N., Katsuragi, T., et al. 2000. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am. J. Respir. Crit. Care Med. 162: 716-722.
18. Poon, B.Y., Raharjo, E., Patel, K.D., Tavener, S., and Kubes, P. 2003. Complexity of inducible nitric oxide synthase. Cellular source determines benefit versus toxicity. Circulation 108: 1107-1112.
19. Preiser, J.C., Zhang, H., Vray, B., Hrabak, A., and Vincent, J.L. 2001. Time course of inducible nitric oxide synthase activity following endotoxin administration in dogs. Nitric Oxide 5: 208-211.
20. Rangel-Frausto, M.S., Pettet, D., Costigan, M., Hwang, T., Davis, C.S., and Wenzel, R.P. 1995. The natural history of the systemic inflammatory responses syndrome (SIRS). J. Am. Med. Assoc. 273: 117-123.
21. Rees, D.D., Cunha, F.Q., Assreuy, J., Herman, A.G., and Moncada, S. 1995. Sequential induction of nitric oxide synthase by corynebacterium parvum in different organs of the mouse. Br. J. Pharmacol. 114: 689-693.
22. Rudkowski, J.C., Barreiro, E., Harfouche, R., Goldberg, P., Kishta, O., D'Orleans-Juste, P., et al. 2004. Role of inducible and neuronal nitric oxide synthases in sepsis-induced pulmonary apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 286: L793-L800.
23. Speyer, C.L., Neff, T.A., Warner, R.L., Guo, R.F., Sarma, J.V., Riedemann, N.C., et al. 2003. Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am. J. Pathol. 163: 2319-2328.
24. Szabó, C., Mitchell, J.A., Thiemermann, C., and Vane, J.R. 1993. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108: 786-792.
25. Szabó, C., Southan, G.J., and Thiemermann, C. 1994. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 91: 12472-12476.
26. Thiemermann, C. 1994. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv. Pharmacol. 28: 45-79.
27. Thiemermann, C., Szabó, C., Mitchell, J.A., and Vane, J.R. 1993. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 90: 267-271.
28. Vromen, A., Arkovitz, M.S., Zingarelli, B., Salzman, A.L., Garcia, V.F., and Szabó, C. 1996. Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock 6: 248-253.
29. Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.P., et al. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411.
30. Wright, C.E., Rees, D.D., and Moncada, S. 1992. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26: 48-57.
31. Wu, C.C., Chen, S.J., Szabó, C., Thiemermann, C., and Vane, J.R. 1995. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114: 1666-1672.
32. Yamada, K., and Nabeshima, T. 1997. Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats. J. Neurochem. 68: 1234-1243.